Isu Group-Hanyang University Begin Technology Transfer and Joint Research in Bio, AI, and Big Data

[Asia Economy Reporter Park So-yeon] Isu Group is strengthening 'Open Innovation' in collaboration with Hanyang University Industry-Academic Cooperation Foundation (hereinafter Hanyang University).

Isu Group announced on the 26th that it has signed a Memorandum of Understanding (MOU) with Hanyang University to foster future convergence businesses and will establish various cooperation systems such as technology transfer and joint research.

The goal is to commercialize technologies in promising future industries such as ▲bio new drug development ▲artificial intelligence (AI) ▲big data.

Isu Group and Hanyang University plan to cooperate primarily in bio new drug development. Currently, Isu Abxis, a bio-pharmaceutical affiliate developing difficult-to-treat anticancer new drugs, is conducting preliminary consultations aiming to derive joint research projects with Hanyang University within the year, and plans to continuously expand the research cooperation relationship in the future.

Isu Group cited the high synergy expectations between Isu Abxis and Hanyang University as the reason for prioritizing the commercialization of bio new drug technology. Isu Abxis is a first-generation biotech company with infrastructure and business experience as a specialized bio company, while Hanyang University possesses original and practical technology patents and research achievements across the bio fields including medicine, pharmacy, life sciences, and engineering.

An official from Isu Group said, "Isu Group’s open innovation, which has taken its first step with joint bio new drug development with Hanyang University, plans to expand into advanced IT fields such as artificial intelligence and big data through IT affiliates like Isu System within the group." He added, "Since Hanyang University is one of the top universities in Korea with excellent faculty and outstanding talents, we expect the speed of Isu Group’s unique technology research and development (R&D) to increase significantly."

Isu Group started in 1969 as Isu Chemical and has grown into a group operating various businesses including bio, IT, and construction, celebrating its 25th anniversary this year. Based on diverse business sectors, it is fostering future industries and technologies such as ▲bio new drugs ▲all-solid-state batteries ▲smart farms, and especially strives to strengthen business competitiveness in line with the rapidly changing era through enhancing open innovation work by nurturing in-house ventures and cooperating with various external organizations.

This content was produced with the assistance of AI translation services.